Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0000912282-25-000059·STONE DANIEL E.
Schedule 13G ownership disclosure
Scinai Immunotherapeutics Ltd.
American Depositary Shares, each representing 4,000 Ordinary Shares, no par value · CUSIP: 09073Q203
Event date: 2024-12-31
- Filing-level shares
- 87,746
- Percent of class
- 9.99%
- Stone Daniel E.
Shares: 87,746 · Class: 9.99%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000912282-25-000059
- Form type
- SCHEDULE 13G/A
- Filer
- STONE DANIEL E.
- CIK
- CIK 1948744
- Filed
- Jan 24, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership